See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Nintendo
Donald Trump
Natural Disasters
Republican Party
Social Media
Baseball
Democratic Party
US Politics
Artificial Intelligence
European Union
Senate
Published • loading... • Updated

Benchmark completes sales of genetics division to Danish investor

Summary by Undercurrent News
Benchmark Genetics is now formally part of Danish science investor Novo Holdings, as well as full owner of its salmon breeding facility in Salten, Norway
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

4 Articles

All
Left
Center
Right
SalmonBusinessSalmonBusiness

Geir Olav Melingen appointed CEO of Benchmark Genetics

Geir Olav Melingen has been appointed Chief Executive Officer of Benchmark Genetics, the company announced this week. Melingen brings extensive experience in aquaculture genetics and animal health, having served in several senior roles at Benchmark Holdings since 2019, including Head of Salmon Health and Genetics and Head of Benchmark Genetics. He previously held senior positions [...]

Read Full Article
Undercurrent NewsUndercurrent News

Benchmark completes sales of genetics division to Danish investor

Benchmark Genetics is now formally part of Danish science investor Novo Holdings, as well as full owner of its salmon breeding facility in Salten, Norway

Read Full Article
thefishsite.comthefishsite.com

Dawn of a new era for Benchmark Genetics

Benchmark Genetics, which has breeding programes for shrimp and salmon, today officially joined the portfolio of Novo Holdings, a Danish life science investor, and has moved its headquarters to Bergen.

Read Full Article
Business Link MagazineBusiness Link Magazine

Benchmark sells genetics business for £260m - Business Link Magazine

Sheffield-based aquaculture biotech firm Benchmark has finalised the sale of its genetics division to Novo Holdings for £260m. The deal, initially reported in November 2024, includes an upfront payment of £230m and contingent consideration of up to £30m. For the year ending 30 June 2024, the genetics business generated £57m in revenue and £14.5m in […]

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Business Link Magazine broke the news in on Tuesday, April 1, 2025.
Sources are mostly out of (0)

Similar News Topics

Norway

Norway

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal